Suggestions appear as you type. Use the up and down arrows to choose one and Enter to open it.

This page's audience our own tag's counts — open to see them
–Visits
–Page views
–Clicks to vendors
–Time on page
–Reading now
Clicks to vendors, by tool
  • –
Top countries
  • –
Devices
  • –

– · visits, page views and clicks counted by our own tag, which counts more than our checked analytics; every figure rounded down · how we count

Deep Genomics AI Workbench review

#10 of 30 in AI Drug Discovery Software

A focused RNA discovery workbench for enterprise teams pairing models with lab validation.

7.4/10Editor score
Deep Genomics AI Workbench7.4 Visit site

Reviewed by iTechGuides Editors · Editorial team · Updated Oct 2026

Deep Genomics AI Workbench is an AI-based drug discovery platform for teams developing RNA therapeutics and other genetic medicines. Its workflow covers disease-related target biology, genetic variant effects on RNA processing and gene regulation, and design of candidates such as steric-blocking oligonucleotides. The enterprise focus and connection to experimental validation make it most relevant to pharmaceutical and biotech teams working on RNA-centered discovery, rather than organizations seeking a broad, self-serve research tool.

The platform’s distinguishing depth is its progression from biological questions to candidate assessment. It uses foundation models including BigRNA, REPRESS, and DeepADAR, predicts on- and off-target effects, and supports fine-tuning models on new datasets. Deep Genomics also describes lab-in-the-loop workflows and orthogonal experimental assays to validate predictions, an important complement to computational outputs in discovery work. This makes the workbench a fit for groups that can connect modeling to experimental programs; teams looking only for a standalone prediction interface may find the workflow more specialized than they need.

Ecosystem and access shape the buying decision. Weights & Biases is integrated into BigRNA workflows, while the product is described as used internally by Deep Genomics and in pharmaceutical partnerships. The company’s current site presents its BioFM Platform, while AI Workbench appears in older official materials, so buyers should clarify the current offering and scope directly with the vendor. Pricing is contact-sales, and there are no published self-serve plans. It is best suited to enterprise teams evaluating a partner-oriented discovery platform; smaller groups seeking transparent tiers or broad-purpose drug discovery software should consider alternatives.

Deep Genomics AI Workbench pros and cons

  • Where it wins
    • Connects RNA target biology with candidate design and effect prediction
    • Models on- and off-target effects of genetic medicines
    • Combines foundation models with lab-in-the-loop validation
  • Where it doesn't
    • Pricing is contact-sales rather than self-serve
    • Workflows are focused on RNA biology and genetic medicines
    • General-purpose software plans are not described

Deep Genomics AI Workbench fact sheet, pricing and score →

Advertiser disclosure: iTechGuides is reader-supported. Vendors can pay for top positions in our rankings and for a place on other products' pages, and we may earn a commission when you click some links. Bought places stand at the number bought; this page and our disclosure say so. Paying vendors may get a fuller, more detailed review from our editors, and that review can change their score. How we rank.

Last updated · How we research and update